Risks for HIV-infected postmenopausal women
Postmenopausal HIV-infected women have a high prevalence of low bone mineral density and high bone turnover placing them at high risk for future bone fractures.
Disproportionate effects of global warming and pollution on disadvantaged communities
Global warming, pollution, and the environmental consequences of energy production impose a greater burden on low-income, disadvantaged communities, and strategies to prevent these inequities are urgently needed.
New tool in the fight against mosquito-borne disease
Earlier this year, researchers showed that they could cut the lives of disease-carrying mosquitoes in half by infecting them with a bacterium they took from fruit flies.
Progress toward AIDS vaccine
Researchers from Thomas Jefferson University are one step closer to developing a vaccine against the AIDS disease.
Routine HIV screening boosts testing
UCSF researchers have found that routinely offering rapid HIV tests to patients in community health centers can significantly increase the number of patients screened for HIV.
New Insight into Selective Binding Properties of Infectious HIV
U.S. Military HIV Research Program researchers have demonstrated that essentially all of the infectious virus particles can bind to the surface of red blood cells isolated from each of 30 normal (non-infected) human donors.
Tailor-made HIV/AIDS treatment closer to reality
An innovative treatment for HIV patients developed by McGill University Health Centre researchers has passed its first clinical trial with flying colours.
HIV-related memory loss linked to Alzheimer’s protein
New research from Washington University School of Medicine in St. Louis suggests HIV-related cognitive deficits share a common link with Alzheimer’s-related dementia.
Some HIV+ patients experience improved outlook on life
A recent study reaffirms that some patients with HIV experience an improved quality of life following their diagnosis.
Tailor-made HIV/AIDS treatment closer to reality
An innovative treatment for HIV patients developed by McGill University Health Centre researchers has passed its first clinical trial with flying colours.